Adolescent Cannabis and Mental Health in Teens: A Careful Reading of a Large New Study

A large 2026 cohort study found that adolescents reporting cannabis use were more likely to later receive diagnoses of psychotic, bipolar, depressive, and anxiety disorders. This Evidence Watch review explains what the paper actually shows, where the associations are strongest, and why the findings deserve clinical attention. It also makes clear what the study does not prove, especially around causality, product type, and individual risk.

Read More

Study: Cannabis Harm Reduction Strategies

This 2025 review maps cannabis harm reduction strategies across legal, social, and health-related domains, from packaging rules and driving policies to cannabis social clubs and product testing. It is useful as a typology and policy overview, but it does not establish which measures work best because the evidence base is mixed and often qualitative. For readers and clinicians, the value here is in clearer thinking about risk reduction, not in assuming these interventions are already proven.

Read More

[no_toc] Study Review โ€ข Psychiatry โ€ข Evidence Interpretation Cannabis Use Disorder Psychiatric Risk: What This 2026 Study Actually Shows A careful review of a large new study comparing cannabis use disorder with...

Read More

DOH sets conditions on proposed medical cannabis legalization | Philippine News Agency

WHY IT MATTERS: If the Philippines establishes a regulated medical cannabis program, patients in the country who currently have no legal access to cannabinoid therapies for conditions like chronic pain, epilepsy, or cancer-related symptoms could gain physician-supervised treatment options through a formal compassionate access pathway. CLINICAL OVERVIEW: The Philippine Department of Health is establishing conditions for a proposed medical cannabis legalization framework that would include compassionate access pathways for patients alongside expanded research initiatives and formal regulatory oversight. This approach mirrors the structured medical cannabis programs that have been successfully implemented in dozens of countries worldwide, where physician-supervised access is paired with robust safety monitoring.

Read More